A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)
研究单位：[1]CSPC Ouyi Pharmaceutical Co., Ltd.[2]The Fourth Hospital of Hebei Medical University,Shijia Zhuang,Hebei,China
研究目的：
The main purpose of this study is to evaluate the efficacy and safety in patients with advanced breast cancer treated with SYHX2011 versus paclitaxel for injection (albumin-bound).
